[Comment] US FDA premarket approval of tDCS depression treatment is not yet scientifically justified | ClinicLens
With major depressive disorder (MDD) being a common psychiatric condition in the world's population, easily accessible treatments with high efficacy and low health risks in early phases of the disorder can mitigate symptom progression and reduce long-term negative effects. T
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.